--SAB Biotherapeutics, Inc., today announced that Michael G. King Jr. has been named Chief Financial Officer. SAB is a clinical-stage biopharmaceutical company with a novel immunotherapy platform ...

Michael (Mike) J. King, 83, of St. Linus parish in Oak Lawn returned to his Creator and Sustainer on August 31, 2024, surrounded by his loving family. Mike was the devoted husband of his beloved wi… ...

San Diego Padres pitcher Michael King reportedly went to extreme lengths to get answers about his shoulder injury. Before ...

Three weeks later, with his rehab program hinging on continued fact-finding, strengthening his shoulder and trying to get his ...

The San Diego Padres have now spent three weeks without Michael King, and according to The Athletic's Dennis Lin, they may need to gear up for another month without their Opening Day Starter ...

San Diego Padres pitcher Michael King made the impressive transition from reliever to starter with the Padres this season. Before joining the Padres, King primarily pitched as a reliever ...

Raises combined $67.1M in private placement plus Tranche warrant exercise with syndicate of leading investorsReceived approval by the Human Resear ...

SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), today announced that Michael G. King Jr. has been named Chief Financial Officer. SAB is a clinical ...

SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), today announced that Michael G. King Jr. has been named Chief Financial Officer. SAB is a clinical ...

SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), today announced that Michael G. King Jr. has been named Chief Financial Officer. SAB is a clinical ...